Control of senescence by CXCR2 and its ligands.
Senescence is an irreversible growth arrest with important physiological implications as it contributes to tumour suppression and may have a role in aging. During senescence, cells suffer profound phenotypic changes affecting amongst others cell morphology and chromatin structure. Senescent cells also undergo significant transcriptional changes, such as the increased production of a plethora of different secreted factors, which are the basis of the so-called senescence-associated secretory phenotype. While some of these factors have been previously shown to possess different pro-tumorigenic activities, we recently demonstrated that the secretion of CXCR2-binding chemokines (such as IL-8 or GROalpha) by senescent cells contribute to reinforce senescence via activation of the p53 pathway. Importantly, our data adds to that presented by several groups suggesting that also other factors secreted during senescence (such as PAI-1, IGFBP-7 or IL-6) contribute to the senescent response. Here, we discuss our findings in the context of the emerging role for secreted factors in regulating senescence through paracrine and/or autocrine mechanisms.
Cell Proliferation Group, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, London, United Kingdom.
Juan C
JC
Acosta
Ana
A
O'Loghlen
Ana
A
Banito
Selina
S
Raguz
Jesús
J
Gil
D000818:Animals; D016922:Cellular Senescence / Q000502:physiology*; D054360:Chemokine CXCL1 / Q000378:metabolism; D004249:DNA Damage; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism; D008024:Ligands; D008954:Models, Biological; D023063:Receptors, Interleukin-8B / Q000378:metabolism*
D054360:Chemokine CXCL1; D016209:Interleukin-8; D008024:Ligands; D023063:Receptors, Interleukin-8B